IS5385A - Statin-LP(A)-tálma-lyfjablöndur við fitudreyra - Google Patents
Statin-LP(A)-tálma-lyfjablöndur við fitudreyraInfo
- Publication number
- IS5385A IS5385A IS5385A IS5385A IS5385A IS 5385 A IS5385 A IS 5385A IS 5385 A IS5385 A IS 5385A IS 5385 A IS5385 A IS 5385A IS 5385 A IS5385 A IS 5385A
- Authority
- IS
- Iceland
- Prior art keywords
- liposuction
- statin
- inhibitor preparations
- preparations
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6943297P | 1997-12-12 | 1997-12-12 | |
| PCT/US1998/023480 WO1999030706A1 (en) | 1997-12-12 | 1998-11-04 | ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5385A true IS5385A (is) | 2000-02-25 |
Family
ID=22088939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5385A IS5385A (is) | 1997-12-12 | 2000-02-25 | Statin-LP(A)-tálma-lyfjablöndur við fitudreyra |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1037623A1 (xx) |
| JP (1) | JP2003524582A (xx) |
| KR (1) | KR20010033017A (xx) |
| AU (2) | AU1306099A (xx) |
| BR (1) | BR9813539A (xx) |
| CA (1) | CA2299397A1 (xx) |
| HU (1) | HUP0100349A3 (xx) |
| IL (1) | IL134364A0 (xx) |
| IS (1) | IS5385A (xx) |
| NO (1) | NO20002965D0 (xx) |
| NZ (1) | NZ502874A (xx) |
| PL (1) | PL343851A1 (xx) |
| WO (1) | WO1999030706A1 (xx) |
| ZA (1) | ZA9811349B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4798814B2 (ja) | 1997-01-07 | 2011-10-19 | アミリン・ファーマシューティカルズ，インコーポレイテッド | 食物摂取低減用のエキセンジンおよびそのアゴニストの使用 |
| EP1076091A1 (en) * | 1999-08-09 | 2001-02-14 | Universite Catholique De Louvain | Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| CA2396157A1 (en) * | 2000-01-10 | 2001-07-19 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| WO2001058443A1 (en) * | 2000-02-10 | 2001-08-16 | Takeda Chemical Industries, Ltd. | TNF- α INHIBITORS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2016467A1 (en) * | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
| WO1993013801A1 (en) * | 1992-01-17 | 1993-07-22 | The Procter & Gamble Company | Treatment for atherosclerosis |
| AU4275793A (en) * | 1992-02-25 | 1993-09-13 | Warner-Lambert Company | Cytoprotective compositions containing pyruvate and antioxidants |
| US5720963A (en) * | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
| US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
| EP0738510A3 (fr) * | 1995-04-20 | 2005-12-21 | L'oreal | Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes |
| JP2000508659A (ja) * | 1996-04-17 | 2000-07-11 | メルク エンド カンパニー インコーポレーテッド | 心血管疾患関連の危険性を低減する組み合わせ療法 |
| NZ503982A (en) * | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
-
1998
- 1998-11-04 JP JP2000538689A patent/JP2003524582A/ja active Pending
- 1998-11-04 KR KR1020007006370A patent/KR20010033017A/ko not_active Application Discontinuation
- 1998-11-04 WO PCT/US1998/023480 patent/WO1999030706A1/en not_active Application Discontinuation
- 1998-11-04 AU AU13060/99A patent/AU1306099A/en not_active Abandoned
- 1998-11-04 EP EP98956562A patent/EP1037623A1/en not_active Ceased
- 1998-11-04 HU HU0100349A patent/HUP0100349A3/hu unknown
- 1998-11-04 PL PL98343851A patent/PL343851A1/xx unknown
- 1998-11-04 IL IL13436498A patent/IL134364A0/xx unknown
- 1998-11-04 NZ NZ502874A patent/NZ502874A/en unknown
- 1998-11-04 BR BR9813539-2A patent/BR9813539A/pt not_active Application Discontinuation
- 1998-11-04 CA CA002299397A patent/CA2299397A1/en not_active Abandoned
- 1998-12-10 ZA ZA9811349A patent/ZA9811349B/xx unknown
-
2000
- 2000-02-25 IS IS5385A patent/IS5385A/is unknown
- 2000-06-09 NO NO20002965A patent/NO20002965D0/no not_active Application Discontinuation
-
2003
- 2003-08-29 AU AU2003244047A patent/AU2003244047A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR9813539A (pt) | 2000-10-10 |
| AU2003244047A1 (en) | 2003-09-25 |
| WO1999030706A1 (en) | 1999-06-24 |
| NO20002965L (no) | 2000-06-09 |
| ZA9811349B (en) | 1999-06-14 |
| JP2003524582A (ja) | 2003-08-19 |
| EP1037623A1 (en) | 2000-09-27 |
| AU1306099A (en) | 1999-07-05 |
| PL343851A1 (en) | 2001-09-10 |
| NO20002965D0 (no) | 2000-06-09 |
| HUP0100349A3 (en) | 2002-02-28 |
| NZ502874A (en) | 2004-03-26 |
| IL134364A0 (en) | 2001-04-30 |
| CA2299397A1 (en) | 1999-06-24 |
| HUP0100349A2 (hu) | 2001-07-30 |
| KR20010033017A (ko) | 2001-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO995433D0 (no) | Protease-inhibitorer | |
| DK0921796T3 (da) | Tetrahydrolipstatinholdige præparater | |
| LU91426I2 (fr) | Fosamprénavir calcium - TELZIR | |
| NO20006716D0 (no) | Proteaseinhibitorer | |
| DK1004669T3 (da) | Hidtil ukendte differentieringsinhibitor | |
| DE69807508D1 (de) | Positionsbestimmung | |
| ID18995A (id) | Amida-amida inhibitor apo b-sekresi/mtp | |
| EE200000044A (et) | Uued ühendid | |
| DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
| DK0958287T3 (da) | Sulfamidmetalloprotease-inhibitorer | |
| NO996578D0 (no) | Urokinase-inhibitorer | |
| DE59910159D1 (de) | Strahlungshärtbare Zubereitungen | |
| NO995434L (no) | Proteaseinhibitorer | |
| NO995435D0 (no) | Protease-inhibitorer | |
| NO995268D0 (no) | Proteaseinhibitorer | |
| DE69818559D1 (de) | Umreifungsmaschine | |
| IS5385A (is) | Statin-LP(A)-tálma-lyfjablöndur við fitudreyra | |
| DE69803763D1 (de) | Schleifmaschine | |
| DK0905025T3 (da) | Omsnøringsapparat | |
| NO995005D0 (no) | En ny fremgangsmåte | |
| DE59804807D1 (de) | Pi-komplex-verbindungen | |
| ID21138A (id) | Teknologi film-tipis untuk head-drum | |
| FI3336U1 (fi) | Jatkolomakkeelle muodostettu korttisovellus | |
| EE04114B1 (et) | HIV-proteaasi inhibiitorid | |
| FI974114A0 (fi) | Skorstenshatt (regntak) |